High tryptophan diet reduces CA1 intraneuronal β‐amyloid in the triple transgenic mouse model of Alzheimer’s disease

Alzheimer’s disease (AD) is a progressive neurodegenerative disease that impairs mnesic functions. The histopathology of the disease is manifested by the accumulation of intracellular β‐amyloid (Aβ) and subsequent formation of neuritic plaques as well as the presence neurofibrillary tangles in specific brain regions associated with learning and memory including the hippocampus. Here, we analysed the effect of chronic (1 month) food diets containing low (LTrP), normal (NTrP) and high tryptophan (HTrP), 0.04, 0.20 and 0.40 g/100 g, respectively, on CA1 serotonin transporter (SERT) fibre density, intraneuronal Aβ deposition and total number of serotonergic (5‐HT) neurons in an AD triple transgenic (3xTg‐AD) mouse model. Nontransgenic (non‐Tg) animals fed with HTrP displayed increased SERT fibre density in CA1 (35%) and in stratum lacunosum moleculare (S.Mol) (48%) compared to LTrP diet. Transgenic animals showed increased SERT fibre density in CA1 S.Mol compared to diet‐matched non‐Tg irrespective of dietary tryptophan content (104% for LTrP, 74% for NTrP and 35% for HTrP); no differences were observed in the total number of 5‐HT neurons neither in the dorsal nor in the median raphe nuclei. However, and more relevant to AD, HTrP diet reduced intraneuronal Aβ density (by a 17%) in transgenic animals compared to transgenic animals fed with NTrP diet. Our results show that increased dietary TrP intake reduces intraneuronal Aβ load in the 3xTg‐AD mouse model of AD, suggesting that enhanced TrP intake and in consequence a potential increase in 5‐HT neurotransmission may be effective in reducing plaque pathology in AD.

[1]  A. Verkhratsky,et al.  Hypermetabolism in a triple-transgenic mouse model of Alzheimer's disease , 2012, Neurobiology of Aging.

[2]  Afshin Borhani Haghighi,et al.  Does Serotonin Augmentation Have Any Effect on Cognition and Activities of Daily Living in Alzheimer's Dementia?: A Double-Blind, Placebo-Controlled Clinical Trial , 2007, Journal of clinical psychopharmacology.

[3]  H. Enesco,et al.  Influence of low tryptophan diet on survival and organ growth in mice , 1986, Mechanisms of Ageing and Development.

[4]  M. Wolfe,et al.  A Portrait of Alzheimer Secretases--New Features and Familiar Faces , 2001, Science.

[5]  M. Mattson,et al.  Prophylactic treatment with paroxetine ameliorates behavioral deficits and retards the development of amyloid and tau pathologies in 3xTgAD mice , 2007, Experimental Neurology.

[6]  C. Scanes,et al.  Effect of a tryptophan deficiency on thyroid gland, growth hormone and testicular functions in chickens. , 1983, The Journal of nutrition.

[7]  G. Take,et al.  The effect of repeated tryptophan administration on body weight, food intake, brain lipid peroxidation and serotonin immunoreactivity in mice , 2006, Molecular and Cellular Biochemistry.

[8]  M. Pákáski,et al.  Imipramine and citalopram facilitate amyloid precursor protein secretion in vitro , 2005, Neurochemistry International.

[9]  M. Mühlethaler,et al.  The serotonin inhibition of high‐voltage‐activated calcium currents is relieved by action potential‐like depolarizations in dissociated cholinergic nucleus basalis neurons of the guinea‐pig , 1998, The European journal of neuroscience.

[10]  W J Riedel,et al.  Serotonin and human cognitive performance. , 2006, Current pharmaceutical design.

[11]  J. O'Brien,et al.  Cognitive deficit induced by acute tryptophan depletion in patients with Alzheimer's disease. , 2000, The American journal of psychiatry.

[12]  R. Vertes,et al.  Projections of the median raphe nucleus in the rat , 1999, The Journal of comparative neurology.

[13]  Y. Levkovitz,et al.  Effect of 5-hydroxytryptophane on behavior and hippocampal physiology in young and old rats , 1994, Neurobiology of Aging.

[14]  C. Lyketsos,et al.  Depression in Alzheimer’s disease: overview and treatment , 2002, Biological Psychiatry.

[15]  M. Lambert,et al.  Intraneuronal amyloid-beta oligomers cause cell death via endoplasmic reticulum stress, endosomal/lysosomal leakage, and mitochondrial dysfunction in vivo , 2011, Alzheimer's & Dementia.

[16]  S. Cooper,et al.  Tryptophan depletion impairs object-recognition memory in the rat: Reversal by risperidone , 2010, Behavioural Brain Research.

[17]  N. Marchionni,et al.  Is Antidepressant Treatment Associated with Reduced Cognitive Decline in Alzheimer’s Disease? , 2008, Dementia and Geriatric Cognitive Disorders.

[18]  Jose Julio Rodriguez,et al.  Serotonin fibre sprouting and increase in serotonin transporter immunoreactivity in the CA1 area of hippocampus in a triple transgenic mouse model of Alzheimer’s disease , 2010, The European journal of neuroscience.

[19]  J. M. Bell,et al.  Amino acid requirements of growing mice: arginine, lysine, tryptophan and phenylalanine. , 1981, The Journal of nutrition.

[20]  M. Mintun,et al.  Serotonin signaling is associated with lower amyloid-β levels and plaques in transgenic mice and humans , 2011, Proceedings of the National Academy of Sciences.

[21]  S. Khaliq,et al.  Enhanced serotonergic neurotransmission in the hippocampus following tryptophan administration improves learning acquisition and memory consolidation in rats. , 2007, Pharmacological reports : PR.

[22]  J. Troncoso,et al.  Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease , 1994, The Lancet.

[23]  Dominic M. Walsh,et al.  Deciphering the Molecular Basis of Memory Failure in Alzheimer's Disease , 2004, Neuron.

[24]  J. Lauder Ontogeny of the Serotonergic System in the Rat: Serotonin as a Developmental Signal a , 1990, Annals of the New York Academy of Sciences.

[25]  J. Cooper,et al.  The enzymic oxidation of tryptophan to 5-hydroxytryptophan in the biosynthesis of serotonin. , 1961, The Journal of pharmacology and experimental therapeutics.

[26]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[27]  J. Miguel-Hidalgo,et al.  Neuroprotection by memantine against neurodegeneration induced by beta-amyloid(1-40). , 2002, Brain research.

[28]  Michael J. Albright,et al.  Increased thalamocortical synaptic response and decreased layer IV innervation in GAP-43 knockout mice. , 2007, Journal of neurophysiology.

[29]  F. Calon,et al.  DHA Improves Cognition and Prevents Dysfunction of Entorhinal Cortex Neurons in 3xTg-AD Mice , 2011, PloS one.

[30]  M. Mattson,et al.  Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles Intracellular Aβ and Synaptic Dysfunction , 2003, Neuron.

[31]  B. Konigsmark,et al.  Methods for counting neurons , 1970 .

[32]  H. Braak,et al.  Neuropathology of Alzheimer’s disease: what is new since A. Alzheimer? , 1999, European Archives of Psychiatry and Clinical Neuroscience.

[33]  W. Klein,et al.  Intraneuronal amyloid β oligomers cause cell death via endoplasmic reticulum stress, endosomal/lysosomal leakage, and mitochondrial dysfunction in vivo , 2011, Journal of neuroscience research.

[34]  C. Kawas,et al.  The CA1 Region of the Human Hippocampus Is a Hot Spot in Alzheimer's Disease , 2000, Annals of the New York Academy of Sciences.

[35]  F. Fadda,et al.  Acute administration of a tryptophan-free amino acid mixture decreases 5-HT release in rat hippocampus in vivo. , 1997, The American journal of physiology.

[36]  C. T. Tsai,et al.  Serotonergic mechanisms involved in the suppression of feeding by 5-HTP in rats. , 1995, The Chinese journal of physiology.

[37]  F. Fadda Tryptophan-Free Diets: A Physiological Tool to Study Brain Serotonin Function. , 2000, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.

[38]  A. Verkhratsky,et al.  Impaired Adult Neurogenesis in the Dentate Gyrus of a Triple Transgenic Mouse Model of Alzheimer's Disease , 2008, PloS one.

[39]  Jose Julio Rodriguez,et al.  Increased hippocampal CA1 density of serotonergic terminals in a triple transgenic mouse model of Alzheimer's disease: an ultrastructural study , 2011, Cell Death and Disease.

[40]  F. Lezoualc’h,et al.  The Human Serotonin 5-HT4 Receptor Regulates Secretion of Non-amyloidogenic Precursor Protein* , 2001, The Journal of Biological Chemistry.

[41]  V. M. Pickel,et al.  Ultrastructure of spared dopamine terminals in caudate-putamen nuclei of adult rats neonatally treated with intranigral 6-hydroxydopamine. , 1992, Brain research. Developmental brain research.

[42]  I. Bezprozvanny,et al.  The dysregulation of intracellular calcium in Alzheimer disease. , 2010, Cell calcium.

[43]  J. Miguel-Hidalgo,et al.  Neuroprotection by memantine against neurodegeneration induced by β-amyloid(1–40) , 2002, Brain Research.

[44]  J. D. McGaugh,et al.  Intraneuronal Aβ Causes the Onset of Early Alzheimer’s Disease-Related Cognitive Deficits in Transgenic Mice , 2005, Neuron.

[45]  S. Gullans,et al.  Drug discovery targeted to the Alzheimer’s APP mRNA 5′-untranslated region , 2007, Journal of Molecular Neuroscience.

[46]  R. Martins,et al.  Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels. , 1985, The EMBO journal.

[47]  D. Selkoe Alzheimer's Disease Is a Synaptic Failure , 2002, Science.

[48]  D. Bayliss,et al.  Effects of serotonin on caudal raphe neurons: inhibition of N- and P/Q-type calcium channels and the afterhyperpolarization. , 1997, Journal of neurophysiology.

[49]  W. A. Saad,et al.  On a possible dual role for the lateral septal area 5-HT1A receptor system in the regulation of water intake and urinary excretion , 2010, Behavioural Brain Research.

[50]  H. Westenberg,et al.  Effects of dietary tryptophan variations on extracellular serotonin in the dorsal hippocampus of rats , 2004, Psychopharmacology.

[51]  K. Gulya,et al.  The cholinergic system in Alzheimer's disease , 1997, Progress in Neurobiology.